Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening.

Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW.

CA Cancer J Clin. 2010 Mar-Apr;60(2):99-119. doi: 10.3322/caac.20063. Review.

2.

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.

Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K; American Society of Clinical Oncology.

J Clin Oncol. 2010 Feb 10;28(5):893-901. doi: 10.1200/JCO.2009.27.0660. Epub 2010 Jan 11. Review. No abstract available.

PMID:
20065170
3.

National Institutes of Health State-of-the-Science Conference Statement: Family History and Improving Health.

Berg AO, Baird MA, Botkin JR, Driscoll DA, Fishman PA, Guarino PD, Hiatt RA, Jarvik GP, Millon-Underwood S, Morgan TM, Mulvihill JJ, Pollin TI, Schimmel SR, Stefanek ME, Vollmer WM, Williams JK.

Ann Intern Med. 2009 Dec 15;151(12):872-7. doi: 10.7326/0003-4819-151-12-200912150-00165.

PMID:
19884615
4.

Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: implications for family health communication interventions.

Koehly LM, Peters JA, Kenen R, Hoskins LM, Ersig AL, Kuhn NR, Loud JT, Greene MH.

Am J Public Health. 2009 Dec;99(12):2203-9. doi: 10.2105/AJPH.2008.154096. Epub 2009 Oct 15.

5.

Perceived intrafamily melanoma risk communication.

Loescher LJ, Crist JD, Siaki LA.

Cancer Nurs. 2009 May-Jun;32(3):203-10. doi: 10.1097/NCC.0b013e31819ae11c.

6.

Colorectal cancer risk prediction tool for white men and women without known susceptibility.

Freedman AN, Slattery ML, Ballard-Barbash R, Willis G, Cann BJ, Pee D, Gail MH, Pfeiffer RM.

J Clin Oncol. 2009 Feb 10;27(5):686-93. doi: 10.1200/JCO.2008.17.4797. Epub 2008 Dec 29.

7.

Developing Family Healthware, a family history screening tool to prevent common chronic diseases.

Yoon PW, Scheuner MT, Jorgensen C, Khoury MJ.

Prev Chronic Dis. 2009 Jan;6(1):A33. Epub 2008 Dec 15.

8.

Population estimates of extended family structure and size.

Garceau A, Wideroff L, McNeel T, Dunn M, Graubard BI.

Community Genet. 2008;11(6):331-42. doi: 10.1159/000133305. Epub 2008 Aug 5.

PMID:
18690001
9.

Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project.

Doria-Rose VP, Marcus PM.

Lung Cancer. 2009 Feb;63(2):295-300. doi: 10.1016/j.lungcan.2008.05.019. Epub 2008 Jun 30.

10.

Family communication after melanoma diagnosis.

Hay J, Shuk E, Brady MS, Berwick M, Ostroff J, Halpern A.

Arch Dermatol. 2008 Apr;144(4):553-4. doi: 10.1001/archderm.144.4.553. No abstract available.

11.

Comparison between cancers identified by state cancer registry, self-report, and death certificate in a prospective cohort study of US radiologic technologists.

Freedman DM, Sigurdson AJ, Doody MM, Love-Schnur S, Linet MS.

Int J Epidemiol. 2006 Apr;35(2):495-7. Epub 2005 Dec 5. No abstract available.

PMID:
16330477
12.

The added value of claims for cancer surveillance: results of varying case definitions.

Penberthy L, McClish D, Manning C, Retchin S, Smith T.

Med Care. 2005 Jul;43(7):705-12.

PMID:
15970786
13.

Cancer risk assessment: quality and impact of the family history interview.

Murff HJ, Byrne D, Syngal S.

Am J Prev Med. 2004 Oct;27(3):239-45.

PMID:
15450637
14.
15.
16.

The sensitivity of Medicare data for identifying incident cases of invasive melanoma (United States).

Barzilai DA, Koroukian SM, Neuhauser D, Cooper KD, Rimm AA, Cooper GS.

Cancer Causes Control. 2004 Mar;15(2):179-84.

PMID:
15017130
17.

Accuracy of reporting of family history of colorectal cancer.

Mitchell RJ, Brewster D, Campbell H, Porteous ME, Wyllie AH, Bird CC, Dunlop MG.

Gut. 2004 Feb;53(2):291-5.

18.

Cancer risk assessment from family history: gaps in primary care practice.

Sifri RD, Wender R, Paynter N.

J Fam Pract. 2002 Oct;51(10):856.

PMID:
12836643
19.

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.

Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH.

J Natl Cancer Inst. 2003 Apr 2;95(7):526-32.

PMID:
12671020
20.

Validation of family history data in cancer family registries.

Ziogas A, Anton-Culver H.

Am J Prev Med. 2003 Feb;24(2):190-8.

PMID:
12568826

Supplemental Content

Support Center